Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Allergy Clin Immunol. 2010 Nov;126(5):1000–1005. doi: 10.1016/j.jaci.2010.05.021

FIG 1. Engraftment kinetics and immune recovery after HCT with nonmyeloablative conditioning in IPEX syndrome.

FIG 1

A) Percent CD3 T cell, CD33 myeloid, and CD56 NK cell donor chimerism levels in sorted peripheral blood cell subsets following HCT. B) Recovery of CD3+, CD4+, CD8+, and CD19 absolute lymphocyte counts following HCT. C) Recovery of T-cell function following HCT assessed by T cell proliferative responses to PHA.